Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 27.86% is 204% above its 5-year average of 9.16%, near the high end of its 5-year range (3.96%–27.86%).
As of the fiscal period ended Sunday, May 31, 2026. 180.45% above its 12-month average of 9.93%.
Reported quarterly debt to assets ratio; no daily interpolation. Q4 FY2026 (2026-05-31): 27.86%.
DEBT TO ASSETS RATIO
27.86%
DEBT TO ASSETS RATIO AVG TTM
9.93%
DEBT TO ASSETS RATIO AVG 3Y
8.06%
DEBT TO ASSETS RATIO AVG 5Y
9.16%
DEBT TO ASSETS RATIO AVG 10Y
8.14%
DEBT TO ASSETS RATIO AVG 15Y
4.36%
DEBT TO ASSETS RATIO AVG 20Y
4.12%
CURRENT VS TTM AVG
+180.45%
CURRENT VS 3Y AVG
+245.71%
CURRENT VS 5Y AVG
+204.04%
CURRENT VS 10Y AVG
+242.26%
CURRENT VS 15Y AVG
+539.37%
CURRENT VS 20Y AVG
+576.94%
SECTOR MEDIAN · HEALTHCARE
0.11%
median of 465 covered companies
CURRENT VS SECTOR MEDIAN
+25226.50%
vs the sector median at left
Biomerica, Inc.
Market Cap
$6.34M
Debt to Assets Ratio
27.86%
TTM Avg
9.93%
3Y Avg
8.06%
5Y Avg
9.16%
Market Cap
$6.44M
Debt to Assets Ratio
0.07%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$6.10M
Debt to Assets Ratio
0.05%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$6.09M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$6.03M
Debt to Assets Ratio
0.06%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$6.72M
Debt to Assets Ratio
0.54%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$6.76M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Biomerica, Inc. (BMRA) | $6.34M | 27.86% | 9.93% | 8.06% | 9.16% |
| Ensysce Biosciences, Inc. (ENSC)vs › | $6.44M | 0.07% | N/A | N/A | N/A |
| Femasys Inc. (FEMY)vs › | $6.10M | 0.39% | N/A | N/A | N/A |
| Cardio Diagnostics Holdings, Inc. (CDIO)vs › | $6.10M | 0.05% | N/A | N/A | N/A |
| Enlivex Therapeutics Ltd. (ENLV)vs › | $6.09M | 0.00% | N/A | N/A | N/A |
| Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR)vs › | $6.03M | 0.06% | N/A | N/A | N/A |
| Bolt Biotherapeutics, Inc. (BOLT)vs › | $6.72M | 0.54% | N/A | N/A | N/A |
| Aclarion, Inc. (ACON)vs › | $6.74M | 0.00% | N/A | N/A | N/A |
| Enveric Biosciences, Inc. (ENVB)vs › | $6.76M | 0.00% | N/A | N/A | N/A |
| Co-Diagnostics, Inc. (CODX)vs › | $6.88M | 0.11% | N/A | N/A | N/A |
Debt/Assets
27.9%
Debt/Equity
0.72
Current Ratio
1.62
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-05-31 | 27.86% |
| 2026-02-28 | 3.96% |
| 2025-11-30 | 4.71% |
| 2025-08-31 | 5.44% |
| 2025-05-31 | 7.70% |
| 2025-02-28 | 7.36% |
| 2024-11-30 | 8.61% |
| 2024-08-31 | 8.98% |
| 2024-05-31 | 8.48% |
| 2024-02-29 | 8.33% |
| 2023-11-30 | 7.92% |
| 2023-08-31 | 7.65% |
| 2023-05-31 | 7.49% |
| 2023-02-28 | 14.35% |
| 2022-11-30 | 12.60% |
| 2022-08-31 | 11.90% |
| 2022-05-31 | 12.13% |
| 2022-02-28 | 8.22% |
| 2021-11-30 | 10.14% |
| 2021-08-31 | 13.58% |
| 2021-05-31 | 13.70% |
| 2021-02-28 | 12.18% |
| 2020-11-30 | 11.60% |
| 2020-08-31 | 10.90% |
| 2020-05-31 | 10.32% |
| 2020-02-29 | 22.28% |
| 2019-11-30 | 26.69% |
| 2019-08-31 | 28.65% |
| 2019-05-31 | 0.00% |
| 2019-02-28 | 0.00% |
| 2018-11-30 | 0.00% |
| 2018-08-31 | 0.00% |
| 2018-05-31 | 0.00% |
| 2018-02-28 | 0.00% |
| 2017-11-30 | 0.00% |
| 2017-08-31 | 0.00% |
| 2017-05-31 | 0.00% |
| 2017-02-28 | 0.00% |
| 2016-11-30 | 0.00% |
| 2016-08-31 | 0.00% |
| 2016-05-31 | 0.00% |
| 2016-02-29 | 0.00% |
| 2015-11-30 | 0.00% |
| 2015-08-31 | 0.00% |
| 2015-05-31 | 0.00% |
| 2015-02-28 | 0.00% |
| 2014-11-30 | 0.00% |
| 2014-08-31 | 0.00% |
| 2014-05-31 | 0.00% |
| 2014-02-28 | 0.00% |
| 2013-11-30 | 0.00% |
| 2013-08-31 | 0.00% |
| 2013-05-31 | 0.00% |
| 2013-02-28 | 0.00% |
| 2012-11-30 | 0.00% |
| 2012-08-31 | 0.00% |
| 2012-05-31 | 0.77% |
| 2012-02-29 | 0.00% |
| 2011-11-30 | 0.23% |
| 2011-08-31 | 0.48% |
| 2011-07-29 | 0.71% |
| 2011-02-28 | 0.97% |
| 2010-11-30 | 1.22% |
| 2010-08-31 | 1.43% |
| 2010-05-31 | 1.61% |
| 2010-02-28 | 1.78% |
| 2009-11-30 | 0.89% |
| 2009-08-31 | 0.83% |
| 2009-05-31 | 1.56% |
| 2009-02-28 | 2.55% |
| 2008-11-30 | 1.79% |
| 2008-08-31 | 3.00% |
| 2008-05-31 | 4.20% |
| 2008-02-29 | 7.46% |
| 2007-11-30 | 7.99% |
| 2007-08-31 | 4.05% |
| 2007-05-31 | 5.47% |
| 2007-02-28 | 8.69% |
| 2006-11-30 | 9.50% |
| 2006-08-31 | 10.21% |
| 2006-05-31 | 11.25% |
| 2006-02-28 | 11.41% |
| 2005-11-30 | 12.71% |
| 2005-08-31 | 5.32% |
| 2005-05-31 | 8.22% |
| 2005-02-28 | 8.78% |
| 2004-11-30 | 8.03% |
| 2004-08-31 | 5.62% |
| 2004-05-31 | 5.70% |
| 2004-02-29 | 1.84% |
| 2003-11-30 | 6.16% |
| 2003-08-31 | 6.29% |
| 2003-05-31 | 5.66% |
| 2003-02-28 | 6.43% |
| 2002-11-30 | 6.40% |
| 2002-08-31 | 6.90% |
